PETER WEBB: Open Payments
NPI 1922024462 · SEQUIM, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 18 payments from 10 companies in 2025. Trend: 2023 $233 · 2024 $371 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $174 |
| Alnylam Pharmaceuticals Inc. | 4 | $122 |
| Boston Scientific Corporation | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $56 |
| Vital Connect, Inc | 1 | $33 |
| BridgeBio Pharma, Inc. | 1 | $29 |
| HEARTFLOW, INC. | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), AMVUTTRA, LEQVIO, CAMZYOS, ACCOLADE SR, VITALPATCH RTM, Attruby, FFRct.
Industry payments across WA — which companies pay providers there.
